Wuyi prices IPO at top end, Meadville in the upper half of the range

The first two Hong Kong IPOs of size this year raise $255 million between them. Retail demand remains strong, triggering full clawbacks on both deals.

This yearÆs first two Hong Kong IPOs of size has priced their respective offerings, raising a combined $255 million amid signs that investor demand remains intact, although not quite as indiscriminate as in December.

The fact that both companies operate in highly competitive industries may have capped the interest somewhat, although syndicate analysts argue that both of them have advantages over their peers that is helping to preserve margins.

Wuyi Pharmaceutical, which was the smaller of the two deals,...

To continue reading, please login or register for free

Click for more on: ipo | pcb | pharmaceuticals | citigroup | hsbc | credit suisse | ubs

Print Edition

FinanceAsia Print Edition


  • 2nd Compliance Summit Southeast Asia

    17 August 2017  |  Singapore
    The 2017 Compliance Summit Southeast Asia will take an in-depth look at the key compliance considerations today with a focus on regulation and new ...